Showing results (2201-2210 of 2,300) with videos related to

Sort By:
Pageof 230
Joint Commission Journal on Quality and Patient Safety|August 21, 2015
Clinical Communities at Johns Hopkins Medicine: An Emerging Approach to Quality ImprovementLois J Gould, Patricia A Wachter, Hanan Aboumatar, et al.
Scientific Reports|March 24, 2021
Evaluation of the gut microbiome in association with biological signatures of inflammation in murine polytrauma and shockSandra A Appiah, Christine L Foxx, Dominik Langgartner, et al.
The Journal of Urology|November 25, 2024
Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary IncontinenceJohn P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, et al.
Internal and Emergency Medicine|September 21, 2020
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation RegistryGiulia Renda, Ladislav Pecen, Giuseppe Patti, et al.
Biochemical Pharmacology|December 7, 2011
Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001Christian R Loehberg, Pamela L Strissel, Ralf Dittrich, et al.
NPJ Vaccines|December 22, 2017
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infectionsSarah T C Elliott, Nicole L Kallewaard, Ebony Benjamin, et al.
Physical Review Letters|April 11, 2015
Coherent electronic wave packet motion in C(60) controlled by the waveform and polarization of few-cycle laser fieldsH Li, B Mignolet, G Wachter, et al.
Nature Medicine|January 3, 2025
Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trialFrank Edelmann, Rolf Wachter, André Duvinage, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2016
Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study designTobias Geisler, Sven Poli, Christoph Meisner, et al.
Frontiers in Immunology|September 28, 2020
Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic ShockRebecca Halbgebauer, Ebru Karasu, Christian K Braun, et al.
Pageof 230